India targets USD 50 billion pharmaceutical exports by 2030: Piyush Goyal

📌 Summary:

• At the Global Ambassador Meet on the Pharmaceutical Sector, Commerce and Industry Minister Piyush Goyal said India pharma sector reflects its commitment to affordable, quality healthcare worldwide, guided by Vasudhaiva Kutumbakam and the One Earth, One Health vision
• India positioned as innovator, manufacturer, reliable supplier of affordable medicines and a contract-manufacturing destination; medicines reach patients in more than 200 countries
• Exports growth: pharma exports rose from about USD 14 billion in FY 2014-15 to about USD 31 billion in FY 2025-26; sector is moving from generics leadership toward innovation-driven growth
• Target: Commerce Secretary Rajesh Agrawal set a goal of USD 50 billion in pharmaceutical exports by 2030 through quality, innovation, regulatory excellence and market diversification
• MoS Jitin Prasada called for greater global collaboration and regulatory cooperation; iPHEX 2026 showcased as a platform for India pharma capabilities

🎯 UPSC Relevance: GS3 — manufacturing, exports, industrial growth; GS2 — health diplomacy and India role in the Global South

📝 Prelims Facts:

• Pharma exports: ~USD 14 bn (FY15) to ~USD 31 bn (FY26); target USD 50 bn by 2030
• Indian medicines reach 200+ countries
• iPHEX = India Pharma & Healthcare Exhibition

🔑 Key Term: Generic medicine — a drug made to be the same as an already-marketed brand-name drug in dosage, safety, strength and intended use, typically sold at lower cost after patent expiry.